drugset / Trial / NCT00051662
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
RandomizedSingle-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether a humanized monoclonal antibody (efalizumab) is safe and effective in the treatment of psoriatic arthritis (PsA)
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | efalizumab | Monoclonal antibody | — | — |